Related Experiment Video
Updated: May 27, 2026
07:33
Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
Published on: December 21, 2011
Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.
Kyung-Sun Heo1, Keigi Fujiwara, Jun-ichi Abe
1Aab Cardiovascular Research Institute, University of Rochester, NY, USA.
Summary
Disturbed blood flow (d-flow) triggers inflammation and apoptosis in endothelial cells (ECs) through protein kinase C zeta (PKCζ) activation. This pathway involves ERK5, KLF2, and p53, contributing to endothelial dysfunction and atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Endothelial Cell Signaling
- Atherosclerosis Pathogenesis
Background:
- Steady laminar flow (s-flow) is atheroprotective, while disturbed flow (d-flow) promotes atherosclerosis.
- Protein kinase C zeta (PKCζ) activation by d-flow elicits pro-inflammatory and pro-apoptotic signals in endothelial cells (ECs).
- D-flow and tumor necrosis factor alpha (TNFα) share PKCζ as a mediator for detrimental EC events.
Purpose of the Study:
- To elucidate a novel signaling pathway linking d-flow to EC inflammation and apoptosis.
- To investigate the role of PKCζ-ERK5 interaction in regulating KLF2/eNOS stability.
- To explore the mechanism of PKCζ-mediated p53-SUMOylation and its contribution to EC apoptosis.
Main Methods:
- Investigated endothelial cell responses to varying flow patterns.
- Utilized molecular signaling assays to identify key protein interactions and modifications.
- Focused on the interplay between PKCζ, ERK5, KLF2, eNOS, and p53.
Main Results:
- D-flow induces EC inflammation and apoptosis via a PKCζ-ERK5 pathway.
- This pathway downregulates KLF2/eNOS stability, promoting an atheroprone environment.
- PKCζ mediates p53-SUMOylation, contributing to EC apoptosis.
- Highlighted mechanisms of endothelial dysfunction related to flow patterns and reactive oxygen species.
Conclusions:
- A novel d-flow-induced signaling cascade involving PKCζ-ERK5, KLF2/eNOS, and p53-SUMOylation drives EC inflammation and apoptosis.
- This pathway provides new insights into endothelial dysfunction and atherosclerosis.
- Understanding these mechanisms may lead to therapeutic strategies targeting vascular diseases.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:17Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.